These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 48596)

  • 21. [Serologic investigations in a village of Haute Volta at the end of a cholera epidemic].
    Saliou P; Dodin A; Lafaye A
    Bull Soc Pathol Exot Filiales; 1977; 70(1):16-22. PubMed ID: 579326
    [No Abstract]   [Full Text] [Related]  

  • 22. Neutralization of cholera enterotoxin-induced steroidogenesis by specific antibody.
    Donta ST
    J Infect Dis; 1974 Mar; 129(3):284-8. PubMed ID: 4593242
    [No Abstract]   [Full Text] [Related]  

  • 23. Study of intestinal immunity against V. cholerae: role of antibody to V. cholerae haemagglutinin in intestinal immunity.
    Chaicumpa W; Atthasisiha N
    Southeast Asian J Trop Med Public Health; 1977 Mar; 8(1):13-8. PubMed ID: 887992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of antibody responses and protective immunity in cholera vaccinated subjects.
    Chaicumpa W; Pacharaprakiti C; Plueksawan W; Atthasishtha N
    Southeast Asian J Trop Med Public Health; 1980 Mar; 11(1):58-66. PubMed ID: 7403955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunity to experimental cholera. I. Protective effect of humoral IgG antitoxin demonstrated by passive immunization.
    Pierce NF; Reynolds HY
    J Immunol; 1974 Sep; 113(3):1017-23. PubMed ID: 4413777
    [No Abstract]   [Full Text] [Related]  

  • 27. [Possibility of quickly determining the sensitivity of cholera vibrio to antibiotics using erythrocytic diagnosticum].
    Roshchin VV; Suleĭmenov BM; Semiotrochev VL
    Lab Delo; 1971; 8():501-2. PubMed ID: 4114051
    [No Abstract]   [Full Text] [Related]  

  • 28. [The evaluation of the vibriocidal antibody test in establishing a diagnosis of cholera or Vibrio carriage].
    Savel'ev VN; Efremenko VI; Gnutov IN; Kiseleva TF; Bogdanov IK; Postovoĭ PP; Latypova MS; Abolina TA; Degtiareva SN; Onatskiĭ II
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (11-12):55-7. PubMed ID: 1301665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraduodenal inoculation of adult rabbits for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains.
    García Imia L; Oliva Hernández R; Cedré Marrero B; Valmaseda Pérez T; García Sánchez H; Talavera Coronel A; Pérez Quiñoy JL; Sierra González G
    Lab Anim Sci; 1998 Oct; 48(5):538-41. PubMed ID: 10090073
    [No Abstract]   [Full Text] [Related]  

  • 30. Antitoxin responses to infections with enterotoxigenic Escherichia coli.
    Sack RB; Jacobs B; Mitra R
    J Infect Dis; 1974 Mar; 129(3):330-5. PubMed ID: 4593243
    [No Abstract]   [Full Text] [Related]  

  • 31. Duration of infection-derived immunity to cholera.
    Levine MM; Black RE; Clements ML; Cisneros L; Nalin DR; Young CR
    J Infect Dis; 1981 Jun; 143(6):818-20. PubMed ID: 7252264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum.
    Cash RA; Music SI; Libonati JP; Snyder MJ; Wenzel RP; Hornick RB
    J Infect Dis; 1974 Jan; 129(1):45-52. PubMed ID: 4809112
    [No Abstract]   [Full Text] [Related]  

  • 33. Cholera antitoxin titrations: a comparative study of fat-cell, ileal-loop, and rabbit-skin assays.
    Curlin CT; Mosley WH; Greenough WB
    J Infect Dis; 1973 Mar; 127(3):294-8. PubMed ID: 4734668
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of phase contrast microscopy and ordinary serologic methods for detection of specific antibodies to non-agglutinating vibrios in human sera].
    Givental' NI; Gritsenko AN; Podosinnikova LS; Ermol'eva ZV
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Feb; (2):54-7. PubMed ID: 4616571
    [No Abstract]   [Full Text] [Related]  

  • 35. [Possibility of purifying cholera toxin (choleragen) and its antibodies by an immunosorption method].
    Zakrevskii VI; Efremenko VI; Lobanov VV; Dolmatova LA
    Zh Mikrobiol Epidemiol Immunobiol; 1979 May; (5):30-4. PubMed ID: 452780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antibacterial immunity in experimental cholera].
    Ujiie A
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):85. PubMed ID: 1240315
    [No Abstract]   [Full Text] [Related]  

  • 37. Magnitude and duration of antitoxic response to human infection with Vibrio cholerae.
    Pierce NF; Banwell JG; Sack RB; Mitra RC; Mondal A
    J Infect Dis; 1970 May; 121():Suppl 121:31+. PubMed ID: 5421427
    [No Abstract]   [Full Text] [Related]  

  • 38. Quantitative differences in antitoxic and antibacterial immunogenesis after live and killed enteral cholera vaccination.
    Bhattacharya P; Mukerjee S
    Indian J Med Res; 1970 Nov; 58(11):1569-77. PubMed ID: 5505346
    [No Abstract]   [Full Text] [Related]  

  • 39. [Patterns in the body's immune response to administration of El Tor vibrio cholera toxin to experimental animals].
    Korovkina GV; Dubrov KF; Pugacheva NN; Urbanovich LIa; Riabova GG
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jan; (1):30-4. PubMed ID: 961236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kappa-type phage detection as a method for the tracing of cholera El Tor carriers.
    Takeya K; Shimodori S; Gomez CZ
    Bull World Health Organ; 1967; 37(5):806-10. PubMed ID: 4870087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.